NO20032489L - Guanidin- og amidinderivater som faktor Xa-inhibitorer - Google Patents

Guanidin- og amidinderivater som faktor Xa-inhibitorer

Info

Publication number
NO20032489L
NO20032489L NO20032489A NO20032489A NO20032489L NO 20032489 L NO20032489 L NO 20032489L NO 20032489 A NO20032489 A NO 20032489A NO 20032489 A NO20032489 A NO 20032489A NO 20032489 L NO20032489 L NO 20032489L
Authority
NO
Norway
Prior art keywords
guanidine
inhibitors
factor
amidine derivatives
amidine
Prior art date
Application number
NO20032489A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032489D0 (no
Inventor
Anuschirwan Peyman
David William Will
Uwe Gerlach
Marc Nazare
Gerhard Zoller
Hans-Peter Nestler
Hans Matter
Fahad Al-Obeidi
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20032489D0 publication Critical patent/NO20032489D0/no
Publication of NO20032489L publication Critical patent/NO20032489L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20032489A 2000-12-06 2003-06-02 Guanidin- og amidinderivater som faktor Xa-inhibitorer NO20032489L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00126750 2000-12-06
PCT/EP2001/013874 WO2002046159A1 (en) 2000-12-06 2001-11-28 Guanidine and amidine derivatives as factor xa inhibitors

Publications (2)

Publication Number Publication Date
NO20032489D0 NO20032489D0 (no) 2003-06-02
NO20032489L true NO20032489L (no) 2003-07-25

Family

ID=8170585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032489A NO20032489L (no) 2000-12-06 2003-06-02 Guanidin- og amidinderivater som faktor Xa-inhibitorer

Country Status (26)

Country Link
US (2) US20020173656A1 (pl)
EP (1) EP1345900B1 (pl)
JP (1) JP4274522B2 (pl)
KR (1) KR20040015036A (pl)
CN (1) CN1479722A (pl)
AR (1) AR033684A1 (pl)
AU (2) AU2002233206B2 (pl)
BR (1) BR0115938A (pl)
CA (1) CA2430518C (pl)
CZ (1) CZ20031554A3 (pl)
DE (1) DE60126143T2 (pl)
DK (1) DK1345900T3 (pl)
EE (1) EE200300192A (pl)
ES (1) ES2278798T3 (pl)
HR (1) HRP20030447A2 (pl)
HU (1) HUP0302604A3 (pl)
IL (2) IL156214A0 (pl)
MX (1) MXPA03004848A (pl)
NO (1) NO20032489L (pl)
NZ (1) NZ526269A (pl)
PL (1) PL362320A1 (pl)
PT (1) PT1345900E (pl)
RU (1) RU2003120070A (pl)
SK (1) SK6862003A3 (pl)
WO (1) WO2002046159A1 (pl)
ZA (1) ZA200303847B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122580B2 (en) * 2002-08-09 2006-10-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
WO2005014533A2 (en) * 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
US7501538B2 (en) 2003-08-08 2009-03-10 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
EP1693069B1 (en) * 2003-10-10 2013-07-24 Chugai Seiyaku Kabushiki Kaisha Remedy for solid tumor
ES2353309T3 (es) 2004-03-08 2011-03-01 Prosidion Ltd. Hidrazidas del ácido pirrolopiridin-2-carboxílico como inhibidores de glucógeno fosforilasa.
ATE424821T1 (de) 2004-12-02 2009-03-15 Prosidion Ltd Pyrrolopyridin-2-karbonsäureamide
DE102006048300A1 (de) 2006-01-26 2007-08-02 Hellstern, Peter, Prof. Dr.med. Inhibitoren des Blutgerinnungsfaktors Xa zur Verwendung als Antikoagulans
TW201035088A (en) 2009-02-27 2010-10-01 Supergen Inc Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
US8507640B2 (en) 2010-08-19 2013-08-13 International Business Machines Corporation Methods of ring opening polymerization and catalysts therefor
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
CA3069720A1 (en) 2017-07-11 2019-01-17 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
SG11202001684PA (en) 2017-10-06 2020-03-30 Forma Therapeutics Inc Inhibiting ubiquitin specific peptidase 30
ES2988920T3 (es) 2018-05-17 2024-11-22 Forma Therapeutics Inc Compuestos bicíclicos fusionados útiles como inhibidores de la peptidasa 30 específica de ubiquitina
PL3860989T3 (pl) 2018-10-05 2023-07-10 Forma Therapeutics, Inc. Sprzężone piroliny, które działają jako inhibitory proteazy 30 swoistej dla ubikwityny (usp30)
WO2020146612A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
WO2020146682A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
EP4667582A1 (en) * 2024-06-20 2025-12-24 Instrumentation Laboratory Company Factor xa reagent
US20250389737A1 (en) * 2024-06-20 2025-12-25 Instrumentation Laboratory Company FACTOR Xa REAGENT
CN121608507B (zh) * 2026-02-02 2026-04-17 肃宁县中原纺织有限责任公司 一种充气浮桥高压气肋外层材料及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201303B (pl) * 1990-07-05 1993-03-01 Hoffmann La Roche
US5506134A (en) 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
US5833982A (en) 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
ES2103181B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Amidas naftalenicas con accion antagonista de los leucotrienos.
HUT76346A (en) * 1994-04-26 1997-08-28 Selectide Corp Factor xa inhibitors
US5792769A (en) * 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
TW542822B (en) * 1997-01-17 2003-07-21 Ajinomoto Kk Benzamidine derivatives
EP1007037A4 (en) * 1997-06-26 2004-10-06 Lilly Co Eli ANTITHROMBOTIC AGENTS
US20020016339A1 (en) * 1998-03-23 2002-02-07 Klein Scott I. Piperididinyl and N-amidinopiperidinyl derivatives
ES2224620T3 (es) * 1998-03-23 2005-03-01 Aventis Pharmaceuticals Inc. Derivados de piperidinilo y n-aminopiperidinilo.
EP0987274A1 (en) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
DE60040676D1 (de) * 1999-09-17 2008-12-11 Millennium Pharm Inc BENZAMIDE UND ÄHNLICHE INHIBITOREN VON FAKTOR Xa

Also Published As

Publication number Publication date
WO2002046159A1 (en) 2002-06-13
US20050143419A1 (en) 2005-06-30
ES2278798T3 (es) 2007-08-16
CA2430518C (en) 2010-06-15
PT1345900E (pt) 2007-03-30
AR033684A1 (es) 2004-01-07
EP1345900A1 (en) 2003-09-24
AU2002233206B2 (en) 2006-06-22
US20020173656A1 (en) 2002-11-21
CN1479722A (zh) 2004-03-03
JP4274522B2 (ja) 2009-06-10
RU2003120070A (ru) 2004-12-27
PL362320A1 (pl) 2004-10-18
IL156214A (en) 2010-05-31
MXPA03004848A (es) 2003-08-19
DK1345900T3 (da) 2007-05-21
KR20040015036A (ko) 2004-02-18
US7435747B2 (en) 2008-10-14
HUP0302604A2 (hu) 2003-11-28
CZ20031554A3 (cs) 2003-08-13
EP1345900B1 (en) 2007-01-17
HUP0302604A3 (en) 2005-09-28
NO20032489D0 (no) 2003-06-02
CA2430518A1 (en) 2002-06-13
SK6862003A3 (en) 2004-02-03
ZA200303847B (en) 2004-04-15
BR0115938A (pt) 2003-12-23
DE60126143D1 (de) 2007-03-08
JP2004515492A (ja) 2004-05-27
IL156214A0 (en) 2003-12-23
HRP20030447A2 (en) 2005-04-30
NZ526269A (en) 2004-11-26
EE200300192A (et) 2003-08-15
AU3320602A (en) 2002-06-18
DE60126143T2 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
DK1345900T3 (da) Guanidin- og amidinderivater som faktor XA-inhibitorer
NO20001687D0 (no) Benzamidinderivater som faktor Xa-inhibitorer
NO20021230L (no) Faktor Xa inhibitorer
NO20041163L (no) Laktam-inneholdende forbindelser og derivater derav som faktor XA-inhibitorer
NO20042592L (no) Indol-2-karboksamider som faktor XA inhibitorer
DK1526132T3 (da) Substituerede oxazolidinoner og deres anvendelse som faktor Xa-hæmmer
NO20013072D0 (no) Nitrogenholdige heterocykler som faktor Xa-inhibitorer
NO20034439L (no) Benzamidinderivater
NO20026010L (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
ATE372988T1 (de) Pyrimidin-derivate
ATE266873T1 (de) Beschichtete gegenstände
NO20002958D0 (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
NO20033350L (no) Imidazolyl-derivater som kortikotropin-frigjörende faktor inhibitorer
DK1549652T3 (da) Kondenserede azolpyrimidinderivater
NO20025810L (no) Faktor VIIA-inhibitoriske (tio)ureaderivater, deres fremstilling og anvendelse
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
DK1395553T3 (da) Pyrrolidinderivater som faktor Xa-inhibitorer
ATE246707T1 (de) Faktor viia inhibitore
NO20030796L (no) Aza-aminosyrederivater (faktor Xa-inhibitorer 15)
NO20014234D0 (no) Pyrazol-3-on-derivater som faktor-Xa-inhibitorer
NO20032754L (no) Urea- og/eller uretanderivater som integrininhibitorer
DE60206376D1 (de) Faktor xa inhibitor
DK1200409T3 (da) Substituerede isoquinolinderivater og deres anvendelse som krampestillende midler
NO20020592D0 (no) Fluorenderivater som integrininhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application